Correlation between clinical features, morphology, and immunophenotype in ALCL
Clinical form of ALCL . | Morphology . | Phenotype . | EMA . | Chimeric ALK . |
---|---|---|---|---|
Systemic | All variants | Mostly T/null | Frequently positive | Positive (∼ 60%) |
Primary cutaneous | Common type to lymphomatoid papulosis | T/null | Some | Negative3-150 |
HIV-related | Common or giant cell–rich | Mostly B | NDA | NDA |
Rarely T/null | NDA | NDA | ||
Secondary | Variable | T/null3-151 | Negative | Negative |
Clinical form of ALCL . | Morphology . | Phenotype . | EMA . | Chimeric ALK . |
---|---|---|---|---|
Systemic | All variants | Mostly T/null | Frequently positive | Positive (∼ 60%) |
Primary cutaneous | Common type to lymphomatoid papulosis | T/null | Some | Negative3-150 |
HIV-related | Common or giant cell–rich | Mostly B | NDA | NDA |
Rarely T/null | NDA | NDA | ||
Secondary | Variable | T/null3-151 | Negative | Negative |